Researcher
Annelii Ny
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Molecular Biodiscovery (Division)
Member
From1 Apr 2013 → 31 Dec 2022
Projects
1 - 5 of 5
- Building towards a patent - Exploitation of the killifish R&D platform to combat neurodegenerative diseasesFrom1 Feb 2024 → TodayFunding: IOF - mandates
- PHGDH-ASM: Phosphoglycerate dehydrogenase (PHGDH) activators as novel antiseizure medications (ASM) with dual mode of actionFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Zebrafish platform for neuroactive drug discovery and safety assessmentFrom1 Jan 2019 → 31 Dec 2020Funding: IOF - technology validation in lab
- Use of fluorescent probes to study pharmacokinetics in zebrafish (Danio rerio) embryos and larvaeFrom12 Dec 2017 → 19 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Zebrafish platform for drug discovery and safety testingFrom1 Jan 2016 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
Publications
11 - 20 of 24
- Cell Imaging Counting as a Novel Ex Vivo Approach for Investigating Drug-Induced Hepatotoxicity in Zebrafish Larvae(2017)
Authors: Bac Nguyen, Stanislav Kislyuk, Duc Hung Pham, Deirdre Cabooter, Pieter Annaert, Peter de Witte, Annelii Ny
- Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction(2017)
Authors: Mohamed Ibrahim, Laleh Khodaparast, Ladan Khodaparast, Fanny Oliveira Arcolino, Przemko Tylzanowski, Annelii Ny, Peter de Witte, Bert van den Heuvel, Elena Levtchenko
Pages: 42583 - 42583 - Use of Zebrafish Larvae as a Multi-Endpoint Platform to Characterize the Toxicity Profile of Silica Nanoparticles(2016)
Authors: Bert De Roo, Mattias Vervaele, Annelii Ny, Daniëlle Copmans, Jean-Pierre Locquet, Peter Hoet, Peter de Witte
- ZEBRAFISH-BASED IDENTIFICATION OF APICULAREN A AS AN ANTICONVULSANT COMPOUND FROM MYXOBACTERIA(2015)
Authors: Daniëlle Copmans, J Herrmann, Annelii Ny, Yifan Zhang, G Adriaenssens, R Mueller, Peter de Witte, Alex Crawford
Pages: 44 - 44 - Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties(2013)
Authors: Frederik De Smet, Katrien De Bock, Maria Georgiadou, Annelii Ny, Max Mazzone, Filip Claes, Koen Poesen, Diether Lambrechts, Marlies Van de Wouwer, Ann Van Schepdael, et al.
Pages: 477 - 488 - A transgenic Xenopus laevis reporter model to study lymphangiogenesis(2013)
Authors: Annelii Ny, Wouter Vandevelde, Manu Beerens, Ilse Geudens, Stéphane Plaisance, Tobias Langenberg, Aernout Luttun, Peter Carmeliet, Mieke Dewerchin
Pages: 882 - 90 - Role of synectin in lymphatic development in zebrafish and frogs(2010)
Authors: Filip Claes, Wouter Vandevelde, Ilse Geudens, Frederik De Smet, Annelii Ny, Mieke Dewerchin, Peter Carmeliet
Pages: 3356 - 3366 - Role of Dll4/Notch in the Formation and Wiring of the Lymphatic Network in Zebra Fish(2010)
Authors: Ilse Geudens, Frederik De Smet, Wouter Vandevelde, Filip Claes, Max Mazzone, Holger Gerhardt, Annelii Ny, Tobias Langenberg, Peter Carmeliet, Mieke Dewerchin
Pages: 1695 - 1702 - Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish.(2010)
Authors: Frederik De Smet, Wouter Vandevelde, Max Mazzone, Annelii Ny, Peter Carmeliet, Mieke Dewerchin
Pages: 1695 - 1702 - Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development(2010)
Authors: Tobias Langenberg, Wouter Vandevelde, Annelii Ny, Mieke Dewerchin, Peter Carmeliet
Pages: 875 - 80
Patents
1 - 7 of 7
- Treatment of pharmacoresistant epilepsy (Inventor)
- Idebenone in the treatment of drug resistant epilepsy (Inventor)
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)